Daihan Pharmaceutical Valuation
| 023910 Stock | KRW 27,250 600.00 2.25% |
At this time, the firm appears to be overvalued. Daihan Pharmaceutical shows a prevailing Real Value of W22207.5 per share. The current price of the firm is W27250.0. Our model computes the value of Daihan Pharmaceutical from reviewing the firm fundamentals such as Profit Margin of 0.10 %, shares outstanding of 6 M, and Current Valuation of 148.23 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Daihan Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Daihan Pharmaceutical is based on 3 months time horizon. Increasing Daihan Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Daihan Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Daihan Stock. However, Daihan Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27250.0 | Real 22207.5 | Hype 27250.0 | Naive 27604.11 |
The real value of Daihan Stock, also known as its intrinsic value, is the underlying worth of Daihan Pharmaceutical Company, which is reflected in its stock price. It is based on Daihan Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Daihan Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Daihan Pharmaceutical CoLtd helps investors to forecast how Daihan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Daihan Pharmaceutical more accurately as focusing exclusively on Daihan Pharmaceutical's fundamentals will not take into account other important factors: Daihan Pharmaceutical Total Value Analysis
Daihan Pharmaceutical CoLtd is presently forecasted to have takeover price of 148.23 B with market capitalization of 182.1 B, debt of 14 B, and cash on hands of 83.73 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Daihan Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
148.23 B | 182.1 B | 14 B | 83.73 B |
Daihan Pharmaceutical Investor Information
About 35.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Daihan Pharmaceutical had 10:1 split on the 29th of April 2002. Based on the analysis of Daihan Pharmaceutical's profitability, liquidity, and operating efficiency, Daihan Pharmaceutical CoLtd is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Daihan Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Daihan Pharmaceutical has an asset utilization ratio of 62.91 percent. This suggests that the Company is making W0.63 for each dollar of assets. An increasing asset utilization means that Daihan Pharmaceutical CoLtd is more efficient with each dollar of assets it utilizes for everyday operations.Daihan Pharmaceutical Ownership Allocation
The market capitalization of Daihan Pharmaceutical is W182.1 Billion. Daihan Pharmaceutical CoLtd retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Daihan Pharmaceutical Profitability Analysis
The company reported the revenue of 171.46 B. Net Income was 22.67 B with profit before overhead, payroll, taxes, and interest of 56.19 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Daihan Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Daihan Pharmaceutical and how it compares across the competition.
About Daihan Pharmaceutical Valuation
The stock valuation mechanism determines Daihan Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Daihan Pharmaceutical. We calculate exposure to Daihan Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Daihan Pharmaceutical's related companies.,Ltd. manufactures and sells various medicinal products in South Korea. ,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. DaihanPharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Daihan Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Daihan Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Daihan Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Daihan Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Daihan Pharmaceutical's revenue streams: Identify Daihan Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Daihan Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Daihan Pharmaceutical's growth potential: Evaluate Daihan Pharmaceutical's management, business model, and growth potential.
- Determine Daihan Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Daihan Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Daihan Stock analysis
When running Daihan Pharmaceutical's price analysis, check to measure Daihan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daihan Pharmaceutical is operating at the current time. Most of Daihan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Daihan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daihan Pharmaceutical's price. Additionally, you may evaluate how the addition of Daihan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |